Spada M et al. |
Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression. |
2006 |
Am. J. Transplant. |
pmid:16771811
|
Saliba F et al. |
Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial. |
2017 |
Am. J. Transplant. |
pmid:28133906
|
Levitsky J and Feng S |
Sirolimus and mTOR inhibitors in liver transplantation: the wheel has come full circle. |
2014 |
Am. J. Transplant. |
pmid:24620373
|
de Fijter JW et al. |
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial. |
2017 |
Am. J. Transplant. |
pmid:28027625
|
Ciancio G et al. |
The use of daclizumab, tacrolimus and mycophenolate mofetil in african-american and Hispanic first renal transplant recipients. |
2003 |
Am. J. Transplant. |
pmid:12859538
|
Singh K et al. |
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. |
2014 |
Am. J. Transplant. |
pmid:25359003
|
Dugast E et al. |
Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27367750
|
Tang Q |
Pharmacokinetics of therapeutic Tregs. |
2014 |
Am. J. Transplant. |
pmid:25358900
|
Wen X et al. |
Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27137884
|
Trofe-Clark J et al. |
Immunosuppression, generic drugs and the FDA. |
2012 |
Am. J. Transplant. |
pmid:22176626
|
Sikma MA et al. |
Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation. |
2015 |
Am. J. Transplant. |
pmid:26053114
|
Latran M |
Response to Klintmalm on the use of generic immunosuppression. |
2012 |
Am. J. Transplant. |
pmid:22176636
|
Ellis CL and Racusen LC |
Mild rise in creatinine six months post kidney transplant. |
2012 |
Am. J. Transplant. |
pmid:22845913
|
de Fontbrune FS et al. |
Veno-occlusive disease of the liver after lung transplantation. |
2007 |
Am. J. Transplant. |
pmid:17697264
|
Abdelmalek MF et al. |
Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial. |
2012 |
Am. J. Transplant. |
pmid:22233522
|
Asrani SK et al. |
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. |
2014 |
Am. J. Transplant. |
pmid:24456026
|
Song L et al. |
ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys. |
2017 |
Am. J. Transplant. |
pmid:27598231
|
Krenzien F et al. |
Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus. |
2017 |
Am. J. Transplant. |
pmid:27754593
|
Gupta G et al. |
Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction. |
2015 |
Am. J. Transplant. |
pmid:25988397
|
Saikali JA et al. |
Sirolimus may promote thrombotic microangiopathy. |
2003 |
Am. J. Transplant. |
pmid:12603218
|
Wang Q et al. |
Biodegradable microsphere-loaded tacrolimus enhanced the effect on mice islet allograft and reduced the adverse effect on insulin secretion. |
2004 |
Am. J. Transplant. |
pmid:15084166
|
Schubert M et al. |
Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients. |
2004 |
Am. J. Transplant. |
pmid:15084173
|
ter Meulen CG et al. |
Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study. |
2004 |
Am. J. Transplant. |
pmid:15084178
|
Borrows R et al. |
Steroid sparing with tacrolimus and mycophenolate mofetil in renal transplantation. |
2004 |
Am. J. Transplant. |
pmid:15476485
|
Hernández-Fisac I et al. |
Tacrolimus-induced diabetes in rats courses with suppressed insulin gene expression in pancreatic islets. |
2007 |
Am. J. Transplant. |
pmid:17725683
|
Suszynski TM et al. |
Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. |
2013 |
Am. J. Transplant. |
pmid:23432755
|
Ferguson R et al. |
Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21114656
|
Frassetto LA and Benet LZ |
Pharmacogenomics and transplantation: where are we? |
2004 |
Am. J. Transplant. |
pmid:15147415
|
MacPhee IA et al. |
The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation. |
2004 |
Am. J. Transplant. |
pmid:15147425
|
Artz MA et al. |
Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. |
2004 |
Am. J. Transplant. |
pmid:15147428
|
Hirsch HH et al. |
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. |
2013 |
Am. J. Transplant. |
pmid:23137180
|
Mujtaba MA et al. |
Conversion from tacrolimus to belatacept to prevent the progression of chronic kidney disease in pancreas transplantation: case report of two patients. |
2014 |
Am. J. Transplant. |
pmid:25179306
|
Flechner SM et al. |
Allotransplantation of cryopreserved parathyroid tissue for severe hypocalcemia in a renal transplant recipient. |
2010 |
Am. J. Transplant. |
pmid:20883540
|
Koefoed-Nielsen PB et al. |
Blood tacrolimus levels and calcineurin phosphatase activity early after renal transplantation. |
2002 |
Am. J. Transplant. |
pmid:12099520
|
BenÃtez CE et al. |
ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation. |
2010 |
Am. J. Transplant. |
pmid:20883560
|
Klintmalm GB |
Immunosuppression, generic drugs and the FDA. |
2011 |
Am. J. Transplant. |
pmid:21794082
|
Böger CA et al. |
Reverse diastolic intrarenal flow due to calcineurin inhibitor (CNI) toxicity. |
2006 |
Am. J. Transplant. |
pmid:16889550
|
Shihab FS et al. |
Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study. |
2013 |
Am. J. Transplant. |
pmid:23167508
|
Tan HP et al. |
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. |
2006 |
Am. J. Transplant. |
pmid:16889606
|
Alloway RR et al. |
A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients. |
2012 |
Am. J. Transplant. |
pmid:22759200
|
Wlodarczyk Z et al. |
Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial. |
2009 |
Am. J. Transplant. |
pmid:19681813
|
Hesselink DA et al. |
Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2. |
2005 |
Am. J. Transplant. |
pmid:15816878
|
Chisholm-Burns MA et al. |
Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients. |
2009 |
Am. J. Transplant. |
pmid:19681814
|
Byrne GW et al. |
Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function. |
2005 |
Am. J. Transplant. |
pmid:15816881
|
Schold JD and Kaplan B |
AZA/tacrolimus is associated with similar outcomes as MMF/tacrolimus among renal transplant recipients. |
2009 |
Am. J. Transplant. |
pmid:19681827
|
Lucey MR et al. |
A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. |
2005 |
Am. J. Transplant. |
pmid:15816894
|
Pillebout E et al. |
Renal histopathological lesions after orthotopic liver transplantation (OLT). |
2005 |
Am. J. Transplant. |
pmid:15816895
|
Madariaga ML et al. |
Kidney-induced cardiac allograft tolerance in miniature swine is dependent on MHC-matching of donor cardiac and renal parenchyma. |
2015 |
Am. J. Transplant. |
pmid:25824550
|
Vanrenterghem Y et al. |
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. |
2005 |
Am. J. Transplant. |
pmid:15636615
|
Sindhi R et al. |
Enhanced donor-specific alloreactivity occurs independently of immunosuppression in children with early liver rejection. |
2005 |
Am. J. Transplant. |
pmid:15636616
|
Shergill AK et al. |
Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. |
2005 |
Am. J. Transplant. |
pmid:15636619
|
Tydén G et al. |
ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. |
2005 |
Am. J. Transplant. |
pmid:15636623
|
Woodle ES et al. |
A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus. |
2005 |
Am. J. Transplant. |
pmid:15636625
|
Mian AN et al. |
Mycoplasma hominis septic arthritis in a pediatric renal transplant recipient: case report and review of the literature. |
2005 |
Am. J. Transplant. |
pmid:15636628
|
Gregoor PS and Weimar W |
Tacrolimus and pure red-cell aplasia. |
2005 |
Am. J. Transplant. |
pmid:15636632
|
Busque S et al. |
Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients. |
2009 |
Am. J. Transplant. |
pmid:19660021
|
Cendales L et al. |
Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report. |
2015 |
Am. J. Transplant. |
pmid:25773260
|
Gao R et al. |
Effects of immunosuppressive drugs on in vitro neogenesis of human islets: mycophenolate mofetil inhibits the proliferation of ductal cells. |
2007 |
Am. J. Transplant. |
pmid:17391142
|
Tremblay S et al. |
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study. |
2017 |
Am. J. Transplant. |
pmid:27340950
|
Padiyar A et al. |
Clinical predictors of proteinuria after conversion to sirolimus in kidney transplant recipients. |
2010 |
Am. J. Transplant. |
pmid:20055793
|
Hardinger KL et al. |
BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. |
2010 |
Am. J. Transplant. |
pmid:20055811
|
Ashman N et al. |
Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy. |
2009 |
Am. J. Transplant. |
pmid:19120084
|
Bhorade SM et al. |
Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. |
2003 |
Am. J. Transplant. |
pmid:14629288
|
Pondrom S |
The AJT report. |
2008 |
Am. J. Transplant. |
pmid:18324976
|
De Simone P et al. |
Everolimus with reduced tacrolimus in liver transplantation. |
2013 |
Am. J. Transplant. |
pmid:23601137
|
Fan DM et al. |
Successful ABO-incompatible living-related intestinal transplantation: a 2-year follow-up. |
2015 |
Am. J. Transplant. |
pmid:25808777
|
Chen G et al. |
A synergistic effect between PG490-88 and tacrolimus prolongs renal allograft survival in monkeys. |
2006 |
Am. J. Transplant. |
pmid:16539628
|
Okabayashi T et al. |
Mobilization of host stem cells enables long-term liver transplant acceptance in a strongly rejecting rat strain combination. |
2011 |
Am. J. Transplant. |
pmid:21883903
|
Hellemons ME et al. |
Former smoking is a risk factor for chronic kidney disease after lung transplantation. |
2011 |
Am. J. Transplant. |
pmid:21883906
|
Maes BD et al. |
Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients. |
2002 |
Am. J. Transplant. |
pmid:12484345
|
Mazariegos GV et al. |
Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. |
2005 |
Am. J. Transplant. |
pmid:15643991
|
Knechtle SJ et al. |
Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. |
2009 |
Am. J. Transplant. |
pmid:19344431
|
Bahra M et al. |
MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course. |
2005 |
Am. J. Transplant. |
pmid:15644002
|
Pallet N et al. |
Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrations. |
2015 |
Am. J. Transplant. |
pmid:25588704
|
Min SI et al. |
Conversion of twice-daily tacrolimus to once-daily tacrolimus formulation in stable pediatric kidney transplant recipients: pharmacokinetics and efficacy. |
2013 |
Am. J. Transplant. |
pmid:23734831
|
Bunnapradist S et al. |
Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. |
2013 |
Am. J. Transplant. |
pmid:23279614
|
Ceschi A et al. |
Acute calcineurin inhibitor overdose: analysis of cases reported to a national poison center between 1995 and 2011. |
2013 |
Am. J. Transplant. |
pmid:23279718
|
Toso C et al. |
Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol. |
2006 |
Am. J. Transplant. |
pmid:16611343
|
Tedesco-Silva H et al. |
Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses. |
2015 |
Am. J. Transplant. |
pmid:25988935
|
Kaplan B and Kirk AD |
Tacrolimus and sirolimus: when bad things happen to good drugs. |
2006 |
Am. J. Transplant. |
pmid:16827845
|
McAlister VC et al. |
Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. |
2006 |
Am. J. Transplant. |
pmid:16827858
|
Gallon L et al. |
Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. |
2006 |
Am. J. Transplant. |
pmid:16827862
|
Grenda R et al. |
A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. |
2006 |
Am. J. Transplant. |
pmid:16827869
|
Vanhove T et al. |
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients. |
2016 |
Am. J. Transplant. |
pmid:27013142
|
Teuteberg JJ et al. |
Alemtuzumab induction prior to cardiac transplantation with lower intensity maintenance immunosuppression: one-year outcomes. |
2010 |
Am. J. Transplant. |
pmid:19889126
|
Haufroid V et al. |
CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. |
2006 |
Am. J. Transplant. |
pmid:17049058
|
Shapiro R et al. |
Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation. |
2007 |
Am. J. Transplant. |
pmid:17908272
|
Rush D et al. |
Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study. |
2007 |
Am. J. Transplant. |
pmid:17908280
|
Turgut F and Akcay A |
Renal function estimation in cirrhosis. |
2009 |
Am. J. Transplant. |
pmid:19519814
|
Irish WD et al. |
Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN database. |
2011 |
Am. J. Transplant. |
pmid:21564522
|
Tricot L et al. |
Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. |
2009 |
Am. J. Transplant. |
pmid:19519819
|
Friman S et al. |
Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21564523
|
Kofler S et al. |
Proton pump inhibitors reduce mycophenolate exposure in heart transplant recipients-a prospective case-controlled study. |
2009 |
Am. J. Transplant. |
pmid:19519820
|
Barbas AS et al. |
Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation. |
2013 |
Am. J. Transplant. |
pmid:23331705
|
Gatault P et al. |
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study. |
2017 |
Am. J. Transplant. |
pmid:27862923
|
Fujishiro J et al. |
Influence of immunosuppression on alloresponse, inflammation and contractile function of graft after intestinal transplantation. |
2010 |
Am. J. Transplant. |
pmid:20642681
|
Margreiter R et al. |
Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial. |
2008 |
Am. J. Transplant. |
pmid:18510632
|
Martinez F et al. |
High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study. |
2010 |
Am. J. Transplant. |
pmid:20642691
|
Miller LW |
Cardiovascular toxicities of immunosuppressive agents. |
2002 |
Am. J. Transplant. |
pmid:12392286
|
Brennan DC et al. |
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. |
2005 |
Am. J. Transplant. |
pmid:15707414
|